The New Journal of Medicine’s article titled: ‘Placebo Effects in Medicine’, published on July 2, 2015, begins by saying ‘The effects of the Placebo are often considered as the ones of an inert substance, but this categorization is deceitful’.
May 30th, 2016
Buenos Aires, Argentina – Activa CRO, a regional full-service contract research organization, today announced the beginning of operations in Ecuador as from June 2016.
Activa is successfully growing in LATAM, adding Ecuador to our existing operations in 8 high quality data producing countries. With similar time zones, culture and language, as well as efficient regulatory timelines, Ecuador is rapidly becoming an important player in the clinical research field, noted Mario Boskis, CEO of Activa CRO
Activa´s footprint in Latin America is strategically expanding, allowing its multinational clients (sponsor´s as well as partner CRO´s ) to jointly manage clinical trials on a global basis.
With its strong regional regulatory and operational expertise, Activa CRO is now covering more than 90% of the clinical research market in Latin America, providing high quality clinical research services since 2003.
Combining a “Boutique” concept of personalized products and services, supported by a robust QA and Medical Monitoring system, the regional CRO remains as a leading service provider to the biotechnology, pharmaceutical and medical device industry.
Activa CRO is now actively working in areas of Oncology, Orphan Drugs, Neglected Diseases (Chagas) Rheumatology, Cardiovascular and First in Human and Pivotal studies in Medical Devices
About Activa CRO
ActivaCro is a privately-owned, regional full-service Contract Research Organization (CRO) based in Buenos Aires, Argentina, with operations in Latin America, providing high quality clinical research services to the biotechnology, pharmaceutical and medical device industries.